FDA will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23-24, 2026, to discuss seven peptides for potential inclusion on the 503A bulks list. An additional five peptides will be ...
Peptides are all anyone wants to talk about right now, and the conversation is about to get louder with HHS Secretary Robert ...
You’ve probably seen compounding making headlines recently, and not for the right reasons. From so-called “personalized” GLP-1s flooding the market to telehealth startups touting hormone “rebalancing” ...
In March, Pharmaceutical Executive reported on Eli Lilly’s efforts to push back against the availability of compounded GLP-1 ...
Health Secretary Robert F. Kennedy Jr. is a self-professed “big fan” of peptides. They have grown in popularity for wellness ...
With Health Secretary Robert F. Kennedy Jr. declaring himself “a big fan of peptides,” the FDA has arranged an advisory ...
Anthony Scaramucci, founder of global investment firm SkyBridge Capital, explained how the "power of compounding" is key to ...
Outraged over a 2012 fungal meningitis outbreak traced back to Framingham, Massachusetts-based drug compounder New England Compounding Center (NECC) that left sixty-four people dead and more than 700 ...
Pharmaceutical companies in Europe are blocking the sale of drugs used for lethal injection in the U.S. That has states that use the drugs turning to compounding pharmacies to create them. David ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results